Cefoperazone & Tazobactam For Inj. 1.125 Gm

What is Cefoperazone & Tazobactam for Injection 1.125 Gm?

Cefoperazone and Tazobactam for Injection is a combination antibiotic formulation containing cefoperazone, a cephalosporin antibiotic, and tazobactam, a beta-lactamase inhibitor. It is intended for healthcare-professional-directed treatment of selected bacterial infections when supported by the approved product information and clinical assessment. The exact component quantities should be confirmed against the product specification.

Uses / Indications

This combination may be used for selected bacterial infections caused by susceptible organisms, subject to the approved product information and applicable treatment guidelines. Potential clinical applications may include:

• Certain respiratory tract infections

• Selected urinary tract infections

• Skin and soft-tissue infections

• Intra-abdominal infections

• Other susceptible bacterial infections specified in approved prescribing information

The exact indications depend on the authorised product labelling, local treatment guidelines and the patient’s clinical condition.

Benefits

• Combines cefoperazone with tazobactam in an injectable formulation.

• Cefoperazone acts against susceptible bacteria by interfering with bacterial cell-wall synthesis.

• Tazobactam inhibits certain beta-lactamase enzymes that can reduce the activity of some beta-lactam antibiotics.

• Provides an injectable option for healthcare-professional-directed treatment when clinically appropriate.

Side Effects

Common or Possible Side Effects

• Diarrhoea or loose stools

• Nausea or vomiting

• Skin rash or itching

• Injection-site discomfort

• Changes in liver-function test results

Serious Side Effects

• Severe allergic reactions, including swelling of the face or throat or difficulty breathing

• Severe or persistent diarrhoea

• Unusual bruising or bleeding

• Severe skin reactions

Seek urgent medical care if a serious allergic reaction or other severe symptom occurs. The precise adverse-effect profile should be verified against the approved information for the specific formulation.

How Does It Work?

Cefoperazone is a cephalosporin antibiotic that interferes with bacterial cell-wall synthesis, leading to the death of susceptible bacteria. Tazobactam inhibits certain beta-lactamase enzymes produced by bacteria, helping protect susceptible beta-lactam antibiotics from enzymatic breakdown. The combination’s effectiveness depends on the bacterial species, susceptibility and approved use of the product.

Dosage Guidelines

• The appropriate dose, frequency and treatment duration must be determined by a qualified healthcare professional.

• Dosing depends on the infection, its severity, the patient’s age and clinical condition, and relevant organ function.

• Preparation, compatibility and administration must follow the approved product information.

• Confirm the exact quantities of cefoperazone and tazobactam represented by the stated 1.125 Gm strength before use.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

This product may not be appropriate for patients who:

• Have a known serious allergy to cefoperazone, tazobactam, cephalosporins or relevant beta-lactam antibiotics.

• Have a history of severe hypersensitivity reactions to related medicines, unless a qualified clinician determines that use is appropriate.

• Have another contraindication listed in the approved product information.

A healthcare professional should review the patient’s allergy history and relevant medical conditions before treatment.

Drug / Product Interactions

Potential interactions or precautions may include:

• Anticoagulants and medicines affecting blood clotting: bleeding risk may increase in some patients.

• Alcohol: cefoperazone has been associated with alcohol-related reactions; follow the approved product warnings and advice from the treating healthcare professional.

• Other antibiotics and medicines: combined use should be assessed for clinical suitability and potential interactions.

Provide the treating professional with a complete list of prescription medicines, non-prescription products and supplements.

Safety Advice

• Use only under appropriate medical supervision.

• Inform the healthcare professional about previous antibiotic allergies, bleeding disorders and relevant liver or kidney conditions.

• Report unusual bruising, bleeding, persistent diarrhoea or signs of an allergic reaction promptly.

• Use antibiotics only for appropriate bacterial infections.

• Do not share the medicine or use leftover antibiotics without medical advice.

General Instructions

• The product should be prepared and administered by trained healthcare personnel.

• Follow the approved instructions for reconstitution, compatibility and administration.

• Inspect the vial and packaging before use; do not use damaged or questionable products.

• Do not use the product beyond its labelled expiry date.

• Follow the prescribed treatment plan and applicable infection-control procedures.

Special Dietary / Lifestyle Tips

• Follow the treating healthcare professional’s advice about diet and fluid intake.

• Ask whether alcohol should be avoided during treatment and for any specified period afterwards.

• Maintain adequate hydration unless medically restricted.

• Seek medical advice if diarrhoea or vomiting becomes persistent or interferes with fluid intake.

Comparison with Other Treatments

Cefoperazone and tazobactam combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Other antibiotic combinations or single-agent antibiotics may be selected depending on the infection, suspected or confirmed bacteria, susceptibility results, allergy history and local treatment guidelines.

This combination should not be considered interchangeable with other injectable antibiotics solely because they share a therapeutic category. Treatment selection should be made by a qualified healthcare professional.

Precautions & Warnings

• Allergy risk: Review previous reactions to cephalosporins, penicillins and other beta-lactam antibiotics.

• Bleeding risk: Additional assessment may be needed for patients with bleeding disorders or those taking anticoagulants.

• Liver and kidney function: Clinical assessment and monitoring may be appropriate for patients with relevant conditions.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires prompt medical assessment.

• Pregnancy and breastfeeding: Use should be assessed by a healthcare professional according to the approved product information.

• Antimicrobial resistance: Use only when clinically indicated and in line with appropriate prescribing guidance.

Can I Use It With Other Medicines?

Cefoperazone and tazobactam may be used with other medicines when clinically indicated, but the combination should be reviewed by a qualified healthcare professional. Particular attention may be needed for anticoagulants and other medicines that affect bleeding risk. Do not start, stop or change medicines without professional advice.

Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Frequently Asked Questions

1. What is Cefoperazone & Tazobactam for Injection used for?

It is a combination antibiotic formulation intended for selected bacterial infections caused by susceptible organisms, according to approved prescribing information.

2. What does tazobactam do in this combination?

Tazobactam inhibits certain beta-lactamase enzymes, which can help protect susceptible beta-lactam antibiotics from enzymatic breakdown.

3. What strength is listed for this product?

The supplied strength is 1.125 Gm. The individual component quantities should be confirmed against the approved product specification.

4. Can this injection treat viral infections?

No. Antibiotics treat susceptible bacterial infections and do not treat viral illnesses such as influenza or the common cold.

5. Who should administer this injection?

Qualified healthcare personnel should prepare and administer the product according to the approved instructions.

6. What side effects may occur?

Possible effects include gastrointestinal symptoms, rash and injection-site discomfort. Severe allergic reactions, significant bleeding or severe diarrhoea require prompt medical attention.

7. How should the product be stored?

Follow the storage conditions specified in the approved product labelling and package insert.